Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Parkinson's Disease

  Free Subscription


02.05.2022

1 Exp Neurol
2 J Biol Chem
1 J Neural Transm (Vienna)
1 J Neurochem
3 Mov Disord
2 Neurology
1 Neuroscience
1 Rev Neurol


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Exp Neurol

  1. PARR-BROWNLIE LC, Itoga CA, Walters JR, Underwood CF, et al
    Oscillatory waveform sharpness asymmetry changes in motor thalamus and motor cortex in a rat model of Parkinson's disease.
    Exp Neurol. 2022 Apr 21:114089. doi: 10.1016/j.expneurol.2022.114089.
    PubMed         Abstract available


    J Biol Chem

  2. XU B, Huang S, Liu Y, Wan C, et al
    Manganese promotes alpha-synuclein amyloid aggregation through the induction of protein phase transition.
    J Biol Chem. 2022;298:101469.
    PubMed         Abstract available

  3. SANGO J, Kakihana T, Takahashi M, Katsuragi Y, et al
    USP10 inhibits the dopamine-induced reactive oxygen species-dependent apoptosis of neuronal cells by stimulating the antioxidant Nrf2 activity.
    J Biol Chem. 2022;298:101448.
    PubMed         Abstract available


    J Neural Transm (Vienna)

  4. RAUSCH WD, Wang F, Radad K
    From the tyrosine hydroxylase hypothesis of Parkinson's disease to modern strategies: a short historical overview.
    J Neural Transm (Vienna). 2022 Apr 23. pii: 10.1007/s00702-022-02488.
    PubMed         Abstract available


    J Neurochem

  5. XUE J, Li G, Ji X, Liu ZH, et al
    Drosophila ZIP13 over-expression or transferrin1 RNAi influences the muscle degeneration of Pink1 RNAi by elevating iron levels in mitochondria.
    J Neurochem. 2022;160:540-555.
    PubMed         Abstract available


    Mov Disord

  6. TANIMURA A, Shen W, Wokosin D, Surmeier DJ, et al
    Pathway-Specific Remodeling of Thalamostriatal Synapses in a Mouse Model of Parkinson's Disease.
    Mov Disord. 2022 Apr 29. doi: 10.1002/mds.29030.
    PubMed         Abstract available

  7. KARAGIANIS JL
    Re: Risk Disclosure in Prodromal Parkinson's Disease.
    Mov Disord. 2022 Apr 28. doi: 10.1002/mds.29038.
    PubMed        

  8. LANGE LM, Gonzalez-Latapi P, Rajalingam R, Tijssen MAJ, et al
    Nomenclature of Genetic Movement Disorders: Recommendations of the International Parkinson and Movement Disorder Society Task Force - An Update.
    Mov Disord. 2022 Apr 28. doi: 10.1002/mds.28982.
    PubMed         Abstract available


    Neurology

  9. LIN J, Li C, Shang H
    Teaching Video NeuroImage: Oculogyric Crises in a 12-Year-Old Girl With Rapid-Onset Dystonia Parkinsonism.
    Neurology. 2022 Apr 28. pii: WNL.0000000000200584.
    PubMed        

  10. DELGADO-ALVARADO M, Gutierrez-Gonzalez A, Marques-Llano S, Riancho J, et al
    Parkinsonism Associated With Striatal Enlarged Perivascular Spaces.
    Neurology. 2022 Apr 28. pii: WNL.0000000000200547.
    PubMed        


    Neuroscience

  11. MORRIS G, Schorge S
    Gene Therapy for Neurological Disease: State of the Art and Opportunities for Next-generation Approaches.
    Neuroscience. 2022;490:309-314.
    PubMed         Abstract available


    Rev Neurol

  12. MELENDEZ-FLORES JD, Irabien-Zuniga M, Cerda-Contreras C, de Los Reyes-Calderon I, et al
    [Parkinson's disease phenotype based on age at onset in Latin American patients: a paired-based analysis].
    Rev Neurol. 2022;74:298-302.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Parkinson's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: